Variants in the coagulation factor 2 receptor (F2R) gene influence the risk of myocardial infarction in men through an interaction with interleukin 6 serum levels

Thrombosis and Haemostasis

Volumn 101, Issue 5, 2009, Pages 943-953

  Gigante, Bruna ^a   Vikström, Max ^a   Meuzelaar, Linda Strömqvist ^b   Chernogubova, Ekaterina ^a   Silveira, Angela ^a   Van't Hooft, Ferdinand ^a   Hamsten, Anders ^a,c   De Faire, Ulf ^a,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Atherothrombosis; Cytokines; Epidemiological studies; Myocardial infarction; Thrombin

Indexed keywords

INTERLEUKIN 6; PROTHROMBIN; RECEPTOR;

ADULT; AGED; ALLELE; ARTICLE; BLOOD LEVEL; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE LOCUS; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; POPULATION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; INTERLEUKIN-6; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; ODDS RATIO; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, PAR-1; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; SWEDEN;

EID: 66149189315     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH08-09-0612     Document Type: Article

References (34)

1. Minami T, Sugiyama A, Wu SQ, et al. Thrombin and phenotypic modulation of the endothelium. Arterioscler Thromb Vasc Biol 2004; 24: 41-53. (Pubitemid 38082410)
2. Gigante B, Bellis A, Visconti R, et al. Retrospective analysis of coagulation factor II receptor (F2R) sequence variation and coronary heart disease in hypertensive patients. Arterioscler Thromb Vasc Biol 2007; 27: 1213-1219. (Pubitemid 46641981)
3. Martorell L, Martinez-Gonzalez J, Rodriguez C, et al. Thrombin and protease-activated receptors (PARs) in atherothrombosis. Thromb Haemost 2008; 99: 305-315.
4. Naldini A, Carney D, Bocci V, et al. Thrombin enhances T cell proliferative responses and cytokine production. Cellular Immunology 1993; 147: 367-377. (Pubitemid 23113934)
5. Chi L, Li Y, Stehno-Bittel L, et al. Interleukin-6 production by endothelial cells via stimulation of protease- activated receptors is amplified by endotoxin and tumor necrosis factor-alpha. J Interferon Cytokine Res 2001; 21: 231-240. (Pubitemid 32679511)
6. Tokunou T, Ichiki I, Takeda K, et al. Thrombin Induces Interleukin-6 Expression Through the cAMP Response Element in Vascular Smooth Muscle Cells Arterioscler Thromb Vasc Biol 2001; 21: 1759.
7. Bennet AM, Prince JA, Fei GZ, et al. Interleukin-6 serum levels and genotypes influence the risk for myocardial infarction. Atherosclerosis 2003; 171: 359-367. (Pubitemid 37486089)
8. Danesh J, Kaptoge S, Mann AG, et al. Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review. PLoS Med 2008; 5: e78.
9. Noto D, Cottone S, Baldassare Cefalu A, et al. Interleukin 6 plasma levels predict with high sensitivity and specificity coronary stenosis detected by coronary angiography. Thromb Haemost 2007; 98: 1362-1367. (Pubitemid 350239111)
10. Debrunner M, Schuiki E, Minder E, et al. Proinflammatory cytokines in acute myocardial infarction with and without cardiogenic shock. Clin Res Cardiol 2008; 97: 298-305.
11. von der Thusen JH, Kuiper J, van Berkel TJ, et al. Interleukins in atherosclerosis: molecular pathways and therapeutic potential. Pharmacol Rev 2003; 55: 133-166. (Pubitemid 36268401)
12. Chackalamannil S, Wang Y, Greenlee WJ, et al. Discovery of a Novel, Orally Active Himbacine-Based Thrombin Receptor Antagonist (SCH 530348) with Potent Antiplatelet Activity. J Med Chem 2008; 51: 3061-3064.
13. Reuterwall C, Hallqvist J, Ahlbom A, et al. Higher relative, but lower absolute risks of myocardial infarction in women than in men: analysis of some major risk factors in the SHEEP study. The SHEEP Study Group. J Intern Med 1999; 246: 161-174. (Pubitemid 29378921)
14. Samnegard A, Silveira A, Lundman P, et al. Serum matrix metalloproteinase-3 concentration is influenced by MMP-3 -1612 5A/6A promoter genotype and associated with myocardial infarction. J Intern Med 2005; 258: 411-419. (Pubitemid 41546556)
15. Hong MG, Bennet AM, de Faire U, et al. Phenotype selection for detecting variable genes: a survey of cardiovascular quantitative traits and TNF locus polymorphism. Eur J Hum Genet 2007; 15: 685-693. (Pubitemid 46830328)
16. Howell W, Jobs M, Gyllensten U, et al. Dynamic allele- specific hybridization. A new method for scoring single nucleotide polymorphisms. Nat Biotechnol 1999; 17: 87-88.
17. Tregouet D, Escolano S, Tiret L, et al. A new algorithm for haplotype-based association analysis: the Stochastic-EM algorithm. Ann Hum Genet 2004; 68: 165-177. (Pubitemid 38379847)
18. Zondervan KT, Cardon LR. Designing candidate gene and genome-wide case-control association studies. Nat Protoc 2007; 2: 2492-2501.
19. Neale BM, Sham PC. The future of association studies: gene-based analysis and replication. Am J Hum Genet 2004; 75: 353-362. (Pubitemid 39095812)
20. Mendall MA, Patel P, Asante M, et al. Relation of serum cytokine concentrations to cardiovascular risk factors and coronary heart disease. Heart 1997; 78: 273-277. (Pubitemid 27431736)
21. Vozarova B, Weyer C, Hanson K, et al. Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion. Obes Res 2001; 9: 414-417. (Pubitemid 33603868)
22. Leger A, Jacques SL, Badar J, et al. Blocking the protease-activated receptor 1-4 heterodimer in platelet- mediated thrombosis. Circulation 2006; 113: 1244-1254. (Pubitemid 43754250)
23. Andrade-Gordon P, Derian CK, Maryanoff BE, et al. Administration of a potent antagonist of protease-activated receptor-1 (PAR-1) attenuates vascular restenosis following balloon angioplasty in rats. J Pharmacol Exp Ther 2001; 298: 34-42. (Pubitemid 32574507)
24. Ku D, J. D. Expression of thrombin receptors in human atherosclerotic coronary arteries leads to an exaggerated vasoconstrictory response in vitro. J Cardiovasc Pharmacol 1997; 30: 649-657. (Pubitemid 27524506)
25. Seo D, Ginsburg GS, Goldschmidt-Clermont PJ. Gene expression analysis of cardiovascular diseases: novel insights into biology and clinical applications. J Am Coll Cardiol 2006; 48: 227-235. (Pubitemid 44026658)
26. Schmegner C, Hoegel J, Vogel W, et al. A comparison of the variability spectra of two genomic loci in a European group of individuals reveals fundamental differences pointing to selection or a population bottleneck. Ann Hum Genet 2007; 71: 370-378. (Pubitemid 46585679)
27. Sorrentino R, De Grazia U, Buzzetti R, et al. An explanation for the neutral effect of DR2 on IDDM susceptibility in central Italy. Diabetes 1992; 41: 904-908.
28. Terry CF, Loukaci V, Green FR. Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem 2000; 275: 18138-18144. (Pubitemid 30414764)
29. Walston JD, Fallin MD, Cushman M, et al. IL-6 gene variation is associated with IL-6 and C-reactive protein levels but not cardiovascular outcomes in the Cardiovascular Health Study. Hum Genet 2007; 122: 485-494. (Pubitemid 350148960)
30. Marin V, Montero-Julian FA, Gres S, et al. The IL-6-soluble IL-6Ralpha autocrine loop of endothelial activation as an intermediate between acute and chronic inflammation: an experimental model involving thrombin. J Immunol 2001; 167: 3435-3442. (Pubitemid 32852589)
31. Burke AP, Farb A, Malcom GT, et al. Effect of risk factors on the mechanism of acute thrombosis and sudden coronary death in women. Circulation 1998; 97: 2110-2116. (Pubitemid 28262117)
32. Riches P, Gooding R, Millar BC, et al. Influence of collection and separation of blood samples on plasma IL-1, IL-6 and TNF-alpha concentrations. J Immunol Methods 1992; 153: 125-131.
33. Drysdale CM, McGraw DW, Stack CB, et al. Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proc Natl Acad Sci USA 2000; 97: 10483-11048
34. Small KM, Mialet-Perez J, Liggett SB. Genetic variation within the beta1-adrenergic receptor gene results in haplotype-specific expression phenotypes. J Cardiovasc Pharmacol 2008; 51: 106-110.